Skip to content
Menu

RBC Capital Reiterates Outperform on Eli Lilly, Maintains $1600 Price Target

Benzinga Newsdesk 19 hours ago

Analyst RatingsNewsReiterationPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

RBC Capital analyst Trung Huynh reiterates Eli Lilly (NYSE:LLY) with a Outperform and maintains $1600 price target.

RBC Capital analyst Trung Huynh reiterates Eli Lilly (NYSE:LLY) with a Outperform and maintains $1600 price target.

Read at benzinga.com